222 related articles for article (PubMed ID: 18785621)
1. Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis.
Silveira MG; Suzuki A; Lindor KD
Hepatology; 2008 Oct; 48(4):1149-56. PubMed ID: 18785621
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis.
Suzuki A; Lymp J; Donlinger J; Mendes F; Angulo P; Lindor K
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):259-64. PubMed ID: 17174610
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.
Jones DE; Metcalf JV; Collier JD; Bassendine MF; James OF
Hepatology; 1997 Nov; 26(5):1138-42. PubMed ID: 9362353
[TBL] [Abstract][Full Text] [Related]
4. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan.
Harada K; Hirohara J; Ueno Y; Nakano T; Kakuda Y; Tsubouchi H; Ichida T; Nakanuma Y
Hepatology; 2013 May; 57(5):1942-9. PubMed ID: 23197466
[TBL] [Abstract][Full Text] [Related]
5. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis.
Deutsch M; Papatheodoridis GV; Tzakou A; Hadziyannis SJ
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):5-9. PubMed ID: 18090982
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis.
Caballería L; Parés A; Castells A; Ginés A; Bru C; Rodés J
Am J Gastroenterol; 2001 Apr; 96(4):1160-3. PubMed ID: 11316164
[TBL] [Abstract][Full Text] [Related]
7. Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid.
Kuiper EM; Hansen BE; Adang RP; van Nieuwkerk CM; Timmer R; Drenth JP; Spoelstra P; Brouwer HT; Kuyvenhoven JP; van Buuren HR;
Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1495-502. PubMed ID: 21389798
[TBL] [Abstract][Full Text] [Related]
8. Hepatic and extrahepatic malignancies in primary biliary cirrhosis.
Floreani A; Baragiotta A; Baldo V; Menegon T; Farinati F; Naccarato R
Hepatology; 1999 May; 29(5):1425-8. PubMed ID: 10216125
[TBL] [Abstract][Full Text] [Related]
9. Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers.
Cavazza A; Caballería L; Floreani A; Farinati F; Bruguera M; Caroli D; Parés A
Hepatology; 2009 Oct; 50(4):1162-8. PubMed ID: 19585656
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis.
Shibuya A; Tanaka K; Miyakawa H; Shibata M; Takatori M; Sekiyama K; Hashimoto N; Amaki S; Komatsu T; Morizane T
Hepatology; 2002 May; 35(5):1172-8. PubMed ID: 11981767
[TBL] [Abstract][Full Text] [Related]
11. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.
Zhang XX; Wang LF; Jin L; Li YY; Hao SL; Shi YC; Zeng QL; Li ZW; Zhang Z; Lau GK; Wang FS
World J Gastroenterol; 2015 Mar; 21(12):3554-63. PubMed ID: 25834320
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.
Yeoman AD; Al-Chalabi T; Karani JB; Quaglia A; Devlin J; Mieli-Vergani G; Bomford A; O'Grady JG; Harrison PM; Heneghan MA
Hepatology; 2008 Sep; 48(3):863-70. PubMed ID: 18752332
[TBL] [Abstract][Full Text] [Related]
13. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.
Trivedi PJ; Lammers WJ; van Buuren HR; Parés A; Floreani A; Janssen HL; Invernizzi P; Battezzati PM; Ponsioen CY; Corpechot C; Poupon R; Mayo MJ; Burroughs AK; Nevens F; Mason AL; Kowdley KV; Lleo A; Caballeria L; Lindor KD; Hansen BE; Hirschfield GM;
Gut; 2016 Feb; 65(2):321-9. PubMed ID: 25567117
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.
Rong G; Wang H; Bowlus CL; Wang C; Lu Y; Zeng Z; Qu J; Lou M; Chen Y; An L; Yang Y; Gershwin ME
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):132-41. PubMed ID: 25762349
[TBL] [Abstract][Full Text] [Related]
15. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for survival and the development of hepatocellular carcinoma in patients with primary biliary cirrhosis.
Tomiyama Y; Takenaka K; Kodama T; Kawanaka M; Sasaki K; Nishina S; Yoshioka N; Hara Y; Hino K
Intern Med; 2013; 52(14):1553-9. PubMed ID: 23857086
[TBL] [Abstract][Full Text] [Related]
17. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Farinati F; Sergio A; Giacomin A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1212-8. PubMed ID: 19465859
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of patients with primary biliary cirrhosis and hepatocellular carcinoma.
Imam MH; Silveira MG; Sinakos E; Gossard AA; Jorgensen R; Keach J; DeCook AC; Lindor KD
Clin Gastroenterol Hepatol; 2012 Feb; 10(2):182-5. PubMed ID: 21963959
[TBL] [Abstract][Full Text] [Related]
19. Incidence of cancer in primary biliary cirrhosis: the Mayo experience.
Nijhawan PK; Therneau TM; Dickson ER; Boynton J; Lindor KD
Hepatology; 1999 May; 29(5):1396-8. PubMed ID: 10216121
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefits of hepatocellular carcinoma surveillance: a single-center, hospital-based study.
Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Motoyoshi Y; Shibata H; Eguchi K
Oncol Rep; 2005 Oct; 14(4):999-1003. PubMed ID: 16142364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
